Archive

SEATTLE, WASHINGTON – FEBRUARY 2020 – Modus Health, the Seattle based medical device and software startup, has been selected by Startup Grind, powered by Google for Startups, for the Startup Exhibition in the Grind category at the 2020 Startup Grind Global Conference held February 11-12th in Silicon Valley. Selected as one of the top 10% of applicants, Modus will be exhibiting the latest iteration of their product, StepWatch 4, and demonstrating how their device and accompanying software radically augment value-based care across the healthcare spectrum.

ABOUT MODUS

Modus is a medical device and software company focused on changing healthcare by facilitating the best in class multivariate ambulation monitoring solutions. Their unequaled accuracy in measuring ambulation, including populations with slow or irregular gaits, is proven in over 400 peer-reviewed journal articles evaluating conditions that impact mobility. The digital biomarkers they provide for their clients, ranging from Veterans hospitals to major pharmaceutical trials, to international hospitals, are predictive of hospital length of stay, hospital readmissions, and disease progression across numerous populations. They are focused on becoming the premier medical device wearable in global usage where ambulation matters.

To learn more about how Modus is leading the way in developing wearable medical devices and ambulation monitoring, please visit www.ModusHealth.com

About Startup Grind

Startup Grind is the largest independent startup community, actively educating, inspiring, and connecting 3,500,000 founders in more than 600 chapters globally. Founded in Silicon Valley, they nurture startup ecosystems in 125+ countries through events, media, and partnerships with organizations such as Google for Startups. Their local monthly events feature successful local founders, innovators, educators and investors who share lessons learned on the road to building great companies. Startup Grind also hosts two flagship conferences annually — the Global Conference and Europe Conference. To date, Startup Grind has helped millions of entrepreneurs find mentorship, connect to partners and hires, pursue funding, and reach new users. Learn more at StartupGrind.com.

###

For Media Inquiries Please Contact:

Teri Chou, Ph.D.
CEO
[email protected]

Startup Grind:
[email protected]

 

SEATTLE, WASHINGTON – FEBRUARY 2020 – Modus Health, the Seattle based medical device and software startup, has been selected by Startup Grind, powered by Google for Startups, for the Startup Exhibition in the Grind category at the 2020 Startup Grind Global Conference held February 11-12th in Silicon Valley. Selected as one of the top 10%…

Read More

Edmonds, Washington / Son, Norway – July 2019   Modus Health earns first clinical care contract with CatoSenteret in Norway. CatoSenteret will be working with Modus Health in the development of its Acute Care System in order to encourage increased patient mobility during their inpatient stay. Modus Health’s CEO, Teri Chou, states “Jan and his team…

Read More

Edmonds, Washington – July 1, 2018  Modus Health hires Chris Green as it’s CTO. As one of the original founding employees of Modus Health from 2013 – 2015, Chris successfully transitioned StepWatch to a new manufacturer and led quality control and product development. From 2015-2016, Chris was acting CTO of a presidential candidate campaign and…

Read More

Edmonds, Washington – December 1, 2017   Following earning Modus Health’s first pharmaceutical contract, Dr. Teri Chou has been promoted from Chief Scientific Officer to CEO. Dr. Chou was a founding employee of Modus Health in 2013 as Director of Clinical Research. She stayed during the restructure of 2016 as the remaining employee. During this time,…

Read More

Washington, D.C. February 27, 2015 – Modus Health, llc, a digital health company focused on actionable physical activity data, today announced that the Department of Veterans Affairs (VA) has approved the use of its StepWatch™ activity tracking device, along with the complimentary Europa™ by Orthocare Innovations, as the only outcomes and utilization devices approved for…

Read More

Washington, D.C. February 13, 2015 – Modus Health, a digital health company focused on providing accurate and actionable physical activity data and analytics to inform clinical decision making, improve efficiency for payors, and optimize outcomes for patients, announced today promising initial study findings which could have a profound effect on the delivery of prosthetic devices…

Read More

Innovative Mobile Health Program to Extend Proven Therapy Solution to Rehabilitation Providers Nationally Chicago, IL and Washington, D.C. October 15, 2014 – The Rehabilitation Institute of Chicago (RIC), America’s best hospital for physical medicine and rehabilitation, and modus health, llc (modus), a digital health company, today announce a collaboration aimed at deploying advanced digital technology…

Read More

Washington, D.C. October 2, 2014 – modus health, llc, a digital health company focused on providing accurate and actionable physical activity data to inform clinical decision making and improve patient outcomes, announced today the formation of its Corporate Advisory Board with eight key appointments. “We are honored to have the support, input and commitment from…

Read More

Washington, D.C. August 12, 2014 – a digital health company focused on providing accurate and actionable physical activity data and analytics to inform clinical decision making, improve efficiency for payors, and optimize outcomes for patients, announced today the formation of its Scientific Advisory Board (SAB) with four key appointments: Thomas George Hornby, PhD, PT, Andrew…

Read More

Improves Clinical Outcomes in Persons with Slow and Irregular Gait, Builds on Clinically Validated Physical Activity Sensor StepWatch™ Washington, D.C. June 26, 2014 — A new healthcare technology company, mōdus health, has been launched to provide accurate, actionable physical activity data and analytics that will improve care efficiency and enhance clinical outcomes in patients with slow and…

Read More